(TKP2021-EGA-23) Támogató: Innovációs és Technológiai Minisztérium
(RRF-2.3.1-21-2022-00003)
(2019-2.1.7-ERA-NET-2021-00015)
TKP2021-EGA-37(TKP2021-EGA-37)
(142192) Támogató: OTKA
The technical difficulty of separating extracellular vesicles (EVs) from plasma proteins
in human blood presents a significant hurdle in EV research, particularly during nano
ultra-high-performance liquid chromatography–tandem mass spectrometric (UHPLC-MS/MS)
analysis, where detecting “vesicular” proteins among abundant plasma proteins is challenging.
Standardisation is a pressing issue in EV research, prompting collaborative global
efforts to address it. While the MISEV guidelines offer valuable recommendations,
unanswered questions remain, particularly regarding sample storage. We compared size
exclusion chromatography (SEC) columns with pore sizes of 35 nm and 70 nm to identify
fractions with minimal contaminating proteins and the highest concentration of small
EVs (sEVs). Following column selection, we explored potential differences in the quality
and quantity of sEVs isolated from platelet-free plasma (PFP) after long-term storage
at −80 °C (>2.5 years) compared to freshly drawn blood. Our methodologically rigorous
study indicates that prolonged storage, under correct storage and processing conditions,
does not compromise sEV quality. Both columns effectively isolated vesicles, with
the 70 nm column exhibiting a higher abundance of “vesicular” proteins. We propose
a relatively rapid and moderately efficient protocol for obtaining a comparatively
pure sEV fraction from plasma, facilitating sEV processing in clinical trials.